Meadow Creek Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$634K Hold
8,260
0.01% 623
2019
Q2
$710K Hold
8,260
0.01% 584
2019
Q1
$488K Hold
8,260
0.01% 695
2018
Q4
$436K Hold
8,260
0.01% 682
2018
Q3
$458K Buy
8,260
+420
+5% +$21.6K 0.01% 761
2018
Q2
$369K Hold
7,840
0.01% 781
2018
Q1
$284K Buy
7,840
+1,400
+22% +$49.2K 0.01% 869
2017
Q4
$234K Buy
6,440
+1,120
+21% +$40.5K 0.01% 942
2017
Q3
$204K Buy
5,320
+1,176
+28% +$49.3K ﹤0.01% 907
2017
Q2
$172K Buy
4,144
+2,128
+106% +$80.9K ﹤0.01% 916
2017
Q1
$71K Buy
2,016
+168
+9% +$5.32K ﹤0.01% 1052
2016
Q4
$57K Buy
+1,848
New +$57.2K ﹤0.01% 1085

Other funds holding RGEN

Meadow Creek Investment Management's RGEN Position: Q3 2019 in Review

Meadow Creek Investment Management held its Repligen (RGEN) position steady in Q3 2019 at 8,260 shares worth $634K. The position accounts for 0.01% of the portfolio, ranked #623.

Meadow Creek Investment Management first reported a position in RGEN in Q4 2016 and has held it in 12 quarters since. The position peaked at $710K in Q2 2019. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Meadow Creek Investment Management held 8,260 shares of Repligen worth $634K as of Q3 2019.
  • Meadow Creek Investment Management left its Repligen share count unchanged in Q3 2019.
  • Repligen made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #623 holding.
  • Meadow Creek Investment Management first reported a position in Repligen in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Repligen position peaked at $710K in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.